Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFT122 (Intraflagellar transport protein 122 homolog) is a core component of the intraflagellar transport-A (IFT-A) complex, a multiprotein structure required for the proper assembly, maintenance, and function of primary cilia. The protein is part of the WD repeat family and contains several WD domains facilitating protein complex formation. IFT122 plays a critical role in the retrograde transport of ciliary proteins, meaning it is involved in moving materials from the ciliary tip back to the base, which is necessary for ciliogenesis, ciliary maintenance, and proper signal transduction—particularly the modulation of Sonic Hedgehog signaling, essential for embryonic development and tissue patterning. Pathogenic variants in IFT122 cause autosomal recessive cranioectodermal dysplasia (Sensenbrenner syndrome), marked by head and facial malformations, short bones, and defects in organs with motile cilia (such as kidney and liver). Dysfunction of IFT122 disrupts cilia formation and the correct trafficking of signaling proteins, explaining the multisystem phenotype seen in human ciliopathies[1][3][4][6].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intraflagellar transport protein 122 homolog (IFT122).